Showing results (121-130 of 217) with videos related to
Sort By:
Pageof 22
Pediatric Blood & Cancer|September 23, 2010
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growthNisha C Kakodkar, Radhika Peddinti, Morris Kletzel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial HospitalAndrew D Campbell, Susan L Cohn, Marleta Reynolds, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastomaHoward M Katzenstein, Susan L Cohn, Richard M Shore, et al.BMJ Open|August 5, 2026
Childhood cancer predisposition study: a prospective registry and biorepository protocolMelissa R Perrino, Suzanne P MacFarland, Luke Maese, et al.Journal of the National Cancer Institute|December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survivalEric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.Cancer Chemotherapy and Pharmacology|January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumorsElizabeth Fox, John M Maris, Susan L Cohn, et al.Biorxiv : the Preprint Server for Biology|July 10, 2023
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signatureMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.Cancer Research|August 6, 2013
A novel algorithm for simplification of complex gene classifiers in cancerRaphael A Wilson, Ling Teng, Karen M Bachmeyer, et al.Clinical Pharmacology and Therapeutics|June 28, 2025
Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment OutcomesYoungwoo Cho, Sami Elahi, Matthew M Jack, et al.Cancer|July 9, 2025
The International Soft Tissue Sarcoma Consortium: The baseline analysis of rhabdomyosarcoma dataGianni Bisogno, Monika Sparber-Sauer, David Rodeberg, et al.Pageof 22